ArticleScience translational medicine2018

Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy.

Marie-Claude Bourgeois-Daigneault et al.PubMed ↗Publisher ↗

No numbers read from the abstract.